The changing healthcare environment and the challenges and opportunities of specialty pharmacy were the biggest themes at Acro Pharmaceutical Services' sixth annual Payer and Managed Care Symposium in Philadelphia last Thursday.
The National Community Pharmacists Association on Wednesday commended seven U.S. Representatives for recently writing the U.S. Centers for Medicare & Medicaid Services to urge the agency to allow independent community pharmacists to continue same-day home delivery of diabetes test supplies to certain Medicare beneficiaries.
A new Walgreens study examining the impact of 90-day medication refills at community pharmacies compared to 30-day refills for Medicaid patients found that across four therapeutic categories, patients with 90-day refills had greater medication adherence and greater persistency, nominal wastage and more cost savings.
With the growth of consumer-driven care and more of the burden of managing costs falling on patients’ shoulders, there’s no doubt that patients are responding to the convenient, cost-effective health care provided by retail health clinics. Further evidence of this is the recent results of the Harris Interactive poll.
They say hindsight is 20/20. With the Supreme Court’s ruling on healthcare reform, the luxury of looking back shows that the National Association of Chain Drug Stores and allies took the right course to battle the pharmacy Medicaid cuts of the Deficit Reduction Act. What we learned should inspire pharmacy to remain tenacious in its continued advocacy on this issue and in confronting all other challenges.
As states grapple with tight budgets, rising Medicaid costs and the anticipated expansion of Medicaid following the Supreme Court’s decision to uphold the Patient Protection and Affordable Care Act, policy-makers should consider how community pharmacists can help reduce expenses.
The idea of pharmacists as the most accessible healthcare professionals isn't just some hokey marketing gimmick: It's a readily observable fact, and one that will become increasingly important as retail pharmacies and retail clinics play a greater role on the front lines of care.
The Department of Health and Human Services on Wednesday announced partnerships with several pharmacies to help customers learn about new Medicare benefits available to them under the Patient Protection and Affordable Care Act.
Just days after Drug Store News reported — once again — that 2012 is proving to be a significant year for the convenient care industry, yet another turn of events further solidified what we’ve been saying for quite some time.
Beginning this month, South Carolina is allowing retail-based health clinics to enroll as providers in Medicaid, a move that will enable Medicaid patients to use clinics for wellness visits, preventive services and to treat acute ailments, according to a local news report.
A cool trillion dollars. That’s what the generic industry said U.S. patients and public and private health plan payers have saved over the last decade by switching from branded to generic prescription drugs at pharmacy counters.
The Florida Pharmacy Association, together with a group of Medicaid patients, independent pharmacies and pharmacists from all over Florida, filed a lawsuit Thursday in Leon County Circuit Court against the Agency for Health Care Administration to seek to restore patient access to qualified Medicaid pharmacy providers.
A new study from Harvard School of Public Health found that expanding Medicaid to low-income adults led to improved health and reduced mortality. It is the first published study to look specifically at the effect of recent state Medicaid expansions on mortality among low-income adults.
The Centers for Medicare and Medicaid Services on Monday hosted a public meeting to entertain a controversial payment adjustment — called "inherent reasonableness" — in reimbursing for non-mail-order diabetes supplies.
There is so much noise out there about the Patient Protection and Affordable Care Act and what it means for America that at times I wish I could just stick a banana in my ear — actually, make that two bananas, one for each ear.
The sweeping healthcare reforms encompassed in the landmark Patient Protection and Affordable Care Act will transform parts of the American healthcare landscape. But the nation’s fiscal challenges and the unsustainable cost increases generated by the U.S. health system also will drive fundamental changes in the way providers, payers and patients search for a more cost-effective and accountable set of solutions to a health system in crisis, said McKesson’s top public policy expert at ideaShare 2012.
As states grapple with tight budgets, rising Medicaid costs and the anticipated expansion of Medicaid following the Supreme Court's decision to uphold the Patient Protection and Affordable Care Act, policymakers should consider how community pharmacists can help reduce expenses. In addition, new evidence offers a fresh reminder of the perils of managed care in Medicaid and the need for proper oversight of managed care entities.
The Supreme Court on Thursday identified the Patient Protection and Affordable Care Act as a tax, which means the constitutionality of the healthcare-reform package cannot be addressed until after that tax is assessed.
While the Supreme Court on Thursday morning left the Patient Protection and Affordable Care Act mostly intact, the court did rule that Congress cannot withhold federal Medicaid spending from a state that does not expand its eligibility requirements under the act.
You want Rite Aid to win. A Rite Aid win represents a proof of concept — that concept being the creation of an effective market-driven loyalty program that incorporates savings on the healthcare services that actually works and in fact cross-pollinates pharmacy patients and front-end shoppers; that concept being that generic waves need not wash out all pharmacy sales volume if a pharmacy retailer can successfully grow ancillary healthcare services, such as immunizations or Rite Aid's new Rite Care Prescription Advisor; that concept being that there is in fact a return on investment from placing a knowledgeable team member armed with a tablet of health information physically in the aisles to proactively engage patients.